Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Tools & Technology › PCR › CARB-X Awards Talis Bio $4.4M

CARB-X Awards Talis Bio $4.4M

May 10, 2018
|
staff reporter

NEW YORK (GenomeWeb) – Talis Biomedical said today that CARB-X has awarded it $4.4 million to further its point-of-care technology for pathogen identification and antibiotic-susceptibility testing.

The award will go toward development of Talis Bio's rapid CLIA-waived molecular diagnostic test for detecting chlamydia and gonorrhea directly from a patient's sample in no more than 20 minutes, as well as a rapid phenotypic antibiotic susceptibility test for gonorrhea.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Apr
29
Featured Webinar

A New Generation of PCR: At-home Testing and Preparing for Emerging Strains of COVID-19

Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

May
13
Featured Webinar

Limits of Detection Matter: New Challenges for SARS-CoV-2 Diagnostics and COVID-19 Patient Management

Sponsored by
LGC SeraCare Life Sciences

As we pass the one-year anniversary of both the COVID-19 pandemic and the first Emergency Use Authorized SARS-CoV-2 PCR detection assays, there remains significant opportunity for clinical laboratories to advance testing and support improved patient management.

May
18
Featured Webinar

Put Your Money Where Your Mouth Is: Tracking and Attacking COVID-19 through State-Wide Saliva Surveillance

Sponsored by
Bio-Rad

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.  

What's Popular?

In Molecular Diagnostics

  1. LGC Biosearch Technologies Gets FDA Emergency Use Authorization for SARS-CoV-2 Test

  2. Amgen, NeoGenomics Partner to Expand Biomarker Testing Access in NSCLC

  3. Women's Health Startup Adyn Raises $2.5M in Seed Funding

  4. Labs Craft SARS-CoV-2 Variant Genotyping Assays for Screening, Surveillance

    Premium

  5. With Luminex Acquisition, DiaSorin to Broaden MDx Portfolio, Expand US Presence

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.